Contact |
General |
Specializations in Countries |
Contribution to the Global Plan |
Declaration |
View this partner's profile
Organization Contact Information |
Name: |
Arunodaya Trust |
Street 1: |
H.No: 1-4/7, Road No 2, Ex Servicemen Colony, |
Street 2: |
Balaji Nagar, Jawahar Nagar GP, Shamirpet Mandal |
City: |
SECUNDERABAD |
Province: |
Telangana |
Post Code: |
500087 |
Country: |
India |
Phone: |
+9104065268999 |
Organization Email: |
arunodayatrust2008@gmail.com |
Web Site: |
http://www.arunodaya.org |
Other Online Presence: |
|
Focal Point Contact Information |
Salutation: |
Mr |
First Name: |
Venkat Rao |
Last Name: |
Khagga |
Title: |
Director |
Email: |
arunodayatrust2008@gmail.com |
Phone: |
919032188999 |
|
Alternate Focal Point Contact Information |
Salutation: |
Mr |
First Name: |
Ranjan |
Last Name: |
Konda |
Title: |
Administrative Officer |
Email: |
ismael.ranjan@gmail.com |
Phone: |
917032219107 |
|
General Information |
Board Constituency: |
Developing Country NGO |
Is your organization legally registered in your country: |
Yes |
If yes, please enter your registration number: |
|
Organization Type - Primary: |
Non-Governmental Organization |
Organization Type - Secondary: |
Faith-based organization (FBO) |
Organization Description: |
Arunodaya Trusts mission is to Arunodaya strives to rebuild the lives of the HIV-positive and those affected by HIV by building their all round capacities and facilitating attitudinal change among them. It seeks to prevent the incidence of child labor, orphan hood and prostitution among them and bring hope to their despairing lives by providing them with some form of assistance of the other. Arunodaya Trust has been serving the families of HIV infected and affected communities in and around Ranagareddy district providing them food and clothing. Shelter for the orphan children who lost their parents. Its a known fact that HIV infected persons are prone to Tuberculosis and we have hands on experience working with them. Arunodaya Trust insists on the following activities for TB Control 1. TB control commitment awareness, and capacity of health systems for service providers and communities. 2. Surveillance 3. Laboratory services ensuring quality diagnosis. 4. Prompt and quality TB care for all 5. MDR- and XDR TB 6. TB/HIV co-infection
|
|
Do you know about the UNHLM declaration: |
|
Specializations / Areas of Work |
Advocacy Delivery of health services and care |
Other Organization Information |
Total number of staff in your organization: |
11 - 25 |
Number of full-time staff who are directly involved with TB: |
1 - 5 |
Number of part-time staff who are directly involved with TB: |
1 - 5 |
Number of volunteers who are directly involved with TB: |
6 - 10 |
|
How did you hear about the Stop TB Partnership: |
Other partners |
If you were informed or referred by another partner of the Stop TB Partnership please tell us who: |
|
Why do you wish join the Stop TB Partnership: |
Network with other partners |
|
Are you a member of a Stop TB national partnership: |
India |
Are you in contact with your national TB programme: |
Yes |
Please tell us how your organization is contributing to your country's national TB control plan: |
Arunodaya Trust ensures Good quality diagnosis. Good quality microscopy allows health workers to see the tubercle bacilli and is essential to identify the infectious patients who need treatment the most. Good quality drugs. An uninterrupted supply of good quality anti-TB drugs must be available. In the RNTCP, a box of medications for the entire treatment is earmarked for every patient registered, ensuring the availability of the full course of treatment the moment the patient is initiated on treatment. Hence in DOTS, the treatment can never interrupt for lack of medicine. Supervised treatment to ensure the right treatment, given in the right way. The RNTCP uses the best anti-TB medications available. But unless treatment is made convenient for patients, it will fail. This is why the heart of the DOTS programme is "directly observed treatment" in which a health worker, or another trained person who is not a family member, watches as the patient swallows the anti-TB medicines in their presence. Systematic monitoring and accountability. The programme is accountable for the outcome of every patient treated. This is done using standard recording and reporting system, and the technique of ‘cohort analysis’. The cure rate and other key indicators are monitored at every level of the health system, and if any area is not meeting expectations, supervision is intensified. The RNTCP shifts the responsibility for cure from the patient to the health system. |
|
Geographical Reach |
Which country is your headquarters located in: |
India |
Which countries do you do operate in: (This includes countries you are conducting activities in) |
India |
Contribution |
Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: |
TB Care Delivery: World TB Day, on March 24th each year, commemorates the day in 1882 when Dr Robert Koch announced that he had discovered the causative agent of tuberculosis, Mycobacterium tuberculosis. It is a day on which the eyes of the public are focused on TB, and ECDC engages in activities aimed to increase the awareness around TB. Each year we have a different theme for our concerted activities and these are produced in the format of a TB Spotlight. Arunodaya Trust has been involved in DOTS services for the 100 families it has been working with and creating an enabling environment.
TB-HIV: Arunodaya Trust is working with 100 families infected by HIV When TB is diagnosed in a patient receiving ART, the patient’s ARV regimen should be assessed with particular attention to potential pharmacokinetic interactions with rifamycins. The patient’s regimen may need to be modified to permit use of the optimal TB treatment regimen. thus ensure proper treatment. |
Declaration |
Declaration of interests:
No conflicts of interest were delacred.
|
Application date: |
March 5, 2015 |
Last updated: |
April 24, 2024 |
|